by ecancer reporter Janet Fricker
The latest issue of PNAS provides evidence of a link between the human-infective parasite Trichomonas vaginalis and the promotion and progression of prostate cancer.
T. vaginalis, a flagellated protozoan parasite, is the causative agent of the most common non viral sexually transmitted infection, infecting approximately 275 million people worldwide.
Several studies have positively associated T. vaginalis infection with increased incidence and severity of prostate cancer, as well as benign prostate hyperplasia.
The magnitude of the association between T. vaginalis seropositivity and overall prostate cancer risk is between 1.23 and 1.43, based on two large, nested case-control studies.
Additionally, it is known that T. vaginalis secretes a protein called T. vaginalis macrophage migration inhibitory factor (TvMIF) that is 47% similar to the proinflammatory cytokine human macrophage migration inhibitory factor (HuMIF).
Since HuMIF is reported to be elevated in prostate cancer and inflammation plays an important role in the initiation and progression of cancers, Patricia Johnson and colleagues, from the University of California, Los Angeles, set out to explore the role of TvMIF in prostate cancer.
The investigators found that:
“This study demonstrates that a specific parasite-derived protein can mimic its human homolog to increase inflammation and cell proliferation, which, in turn, may result in the promotion and progression of prostate cancer,” write the authors.
More studies on T. vaginalis and cancer, along with parasite mimics of human cytokines, they add, will aid understanding of the extent to which this chronically infective parasite affects its hosts.
Reference:
O Twu, D Dessi, A Vu, et al. Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. PNAS.
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.